Form 4: Rezolute CFO Daron Evans Boosts Stake with RSU & Options

Rezolute Inc.'s CFO, Daron Evans, increased his beneficial ownership through the acquisition of 107,000 restricted stock units and 63,000 employee stock options.

Summary

• Daron Evans, Chief Financial Officer of Rezolute, Inc. (RZLT), reported changes in his beneficial ownership.
• Acquired 107,000 common shares in the form of Restricted Stock Units (RSUs) at a price of $0, which vest annually over a three-year period with the first vesting on December 1, 2026.
• Acquired 63,000 employee stock options with an exercise price of $10.16, which vest 1/36th monthly beginning on December 19, 2025, and expire on November 19, 2035.
• Following these transactions, Mr. Evans directly beneficially owns 375,900 common shares and 63,000 employee stock options.
• Indirect beneficial ownership includes 23,000 common shares held by minor child #1, 20,000 by his spouse, 4,500 by minor child #2, 4,500 by minor child #3, and 40,000 by PoC Capital LLC, which he manages but disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 7

Explanation: The acquisition of restricted stock units and stock options by the CFO indicates a strong alignment of management's interests with the long-term success of the company and its shareholders. This type of insider activity is typically viewed favorably as it suggests confidence in future performance.

Positives

• CFO Daron Evans increased his direct beneficial ownership by 107,000 common shares (RSUs) and 63,000 employee stock options, signaling strong insider confidence.
• The acquisition of RSUs at a $0 price and stock options at $10.16 represents equity grants from the company, aligning management's long-term interests with those of shareholders.
• The multi-year vesting schedules for both RSUs (over three years) and options (monthly over 36 months) demonstrate a sustained commitment from the CFO to the company's future performance and value creation.

Risks

• The ultimate value realized from the acquired RSUs and stock options is directly dependent on the future performance of Rezolute, Inc.'s stock price, exposing the CFO to market fluctuations.
• The vesting of both RSUs and options is contingent on continued employment and potentially other performance criteria, meaning the full economic benefit is not immediately guaranteed or realized.

Future Outlook

The vesting schedules for the restricted stock units (annually over three years starting December 1, 2026) and employee stock options (1/36th monthly beginning December 19, 2025) indicate a long-term incentive structure designed to align the CFO's interests with the company's sustained performance and future growth.

Industry Context

Grants of restricted stock units and stock options to key executives like the CFO are standard practice in the biotechnology and pharmaceutical industries. These equity incentives are widely used to attract, retain, and motivate talent, aligning their long-term financial interests with the company's success and shareholder value creation.

Comparison to Industry Standards

• The structure of equity grants, including RSUs with multi-year vesting and stock options with a 10-year term and monthly vesting, is consistent with common compensation practices for executive officers in publicly traded companies, particularly within the biotech sector.

Related Party Transactions

• Daron Evans indirectly beneficially owns 40,000 common shares held by PoC Capital LLC, a California limited liability company managed by him. He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: The equity grants align the CFO's financial incentives with shareholder value creation, potentially leading to more focused long-term decision-making and increased confidence.
• Employees: The provision of equity grants to a key executive demonstrates the company's commitment to retaining top talent, which can positively impact overall employee morale and organizational stability.

Next Steps

• Continued vesting of 107,000 restricted stock units annually over three years, with the first vesting on December 1, 2026.
• Continued monthly vesting of 63,000 employee stock options, beginning December 19, 2025.

Key Dates

Keywords

RZLT, Rezolute, Daron Evans, CFO, Form 4, insider transaction, stock options, restricted stock units, beneficial ownership, equity compensation